{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:23:28Z","timestamp":1788798208901,"version":"build-2803163510"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Identifying and treating patients with acute Q fever who are at an increased risk of progressing to persistent disease is crucial for preventing future complications. In this study, we share our decade-long clinical experience with acute Q fever, highlighting the challenges that clinicians encounter from making an initial diagnosis and performing risk stratification to determining the appropriate prophylaxis regimen and duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrieved records of adult Mayo Clinic patients (\u226518 years) with positive Coxiella burnetii serology results between 1 January 2012 and 31 March 2022. Patients with Q fever anti\u2013phase II immunoglobulin G \u22651:256 by indirect immunofluorescence were further analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-one patients were included. Their median age was 58 years (IQR, 50\u201364), and the majority were men (84%). Acute hepatitis (29%), flu-like illness (25.8%), and pneumonia (16%) were the most common presentations. Thirteen patients (42%) received antibiotic prophylaxis to prevent disease progression, with significant variation in the indications and duration across physicians. The combination of doxycycline and hydroxychloroquine was the preferred regimen. Prophylaxis was administered for a median 333 days (IQR, 168\u2013414). Four patients (13%) progressed to Q fever native valve infective endocarditis, with elevated anticardiolipin immunoglobulin G levels being the sole risk factor in 2 cases. The small sample size precluded drawing conclusions on the impact of prophylaxis in preventing disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Management of acute Q fever is complicated by the lack of comprehensive clinical guidelines leading to varied clinical practices. There is a critical need for randomized trials to establish robust evidence-based protocols for management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofae277","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T08:05:35Z","timestamp":1715241935000},"source":"Crossref","is-referenced-by-count":8,"title":["Acute\n                    <i>Coxiella burnetii<\/i>\n                    Infection: A 10-Year Clinical Experience at a Tertiary Care Center in the United States"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4331-5259","authenticated-orcid":false,"given":"Said","family":"El Zein","sequence":"first","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug W","family":"Challener","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-6214","authenticated-orcid":false,"given":"Nischal","family":"Ranganath","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan B","family":"Khodadadi","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6886-2294","authenticated-orcid":false,"given":"Elitza S","family":"Theel","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4955-5544","authenticated-orcid":false,"given":"Omar M","family":"Abu Saleh","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"2024062715575459200_ofae277-B1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.idc.2008.03.002","article-title":"Q fever","volume":"22","author":"Tissot-Dupont","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"3\u20134","key":"2024062715575459200_ofae277-B2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.vetmic.2009.07.016","article-title":"Q fever","volume":"140","author":"Angelakis","year":"2010","journal-title":"Vet Microbiol"},{"issue":"RR-03","key":"2024062715575459200_ofae277-B3","first-page":"1","article-title":"Diagnosis and management of Q fever\u2014United States, 2013: recommendations from CDC and the Q Fever Working Group","volume":"62","author":"Anderson","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"2024062715575459200_ofae277-B4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3201\/eid1804.111478","article-title":"Identification of risk factors for chronic Q fever, the Netherlands","volume":"18","author":"Kampschreur","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2024062715575459200_ofae277-B5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/zph.12896","article-title":"Acute and chronic Q fever national surveillance\u2014United States, 2008\u20132017","volume":"69","author":"Cherry","year":"2022","journal-title":"Zoonoses Public Health"},{"key":"2024062715575459200_ofae277-B6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4269\/ajtmh.14-0503","article-title":"Q fever in the United States: summary of case reports from two national surveillance systems, 2000\u20132012","volume":"92","author":"Dahlgren","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"2024062715575459200_ofae277-B7","author":"Centers for Disease Control and Prevention, Division of Vector Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases"},{"key":"2024062715575459200_ofae277-B8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/cdli.1.2.189-196.1994","article-title":"Q fever serology: cutoff determination for microimmunofluorescence","volume":"1","author":"Dupont","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"2024062715575459200_ofae277-B9"},{"key":"2024062715575459200_ofae277-B10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00045-16","article-title":"From Q fever to Coxiella burnetii infection: a paradigm change","volume":"30","author":"Eldin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"2024062715575459200_ofae277-B11","doi-asserted-by":"crossref","first-page":"e181580","DOI":"10.1001\/jamanetworkopen.2018.1580","article-title":"Clinical features and complications of Coxiella burnetii infections from the French National Reference Center for Q fever","volume":"1","author":"Melenotte","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2024062715575459200_ofae277-B12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-642-48351-6_13","volume-title":"Rapid cycle real-time PCR\u2014methods and applications: microbiology and food analysis","author":"Stemmler","year":"2002"},{"key":"2024062715575459200_ofae277-B13","doi-asserted-by":"crossref","first-page":"ofx192","DOI":"10.1093\/ofid\/ofx192","article-title":"Coxiella burnetii multilevel disk space infection, epidural abscess, and vertebral osteomyelitis secondary to contiguous spread from infected abdominal aortic aneurysm or graft: report of 4 cases acquired in the US and review of the literature","volume":"4","author":"Virk","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2024062715575459200_ofae277-B14"},{"key":"2024062715575459200_ofae277-B15","doi-asserted-by":"crossref","first-page":"786.e7","DOI":"10.1016\/j.amjmed.2014.03.013","article-title":"Culture-negative prosthetic joint arthritis related to Coxiella burnetii","volume":"127","author":"Million","year":"2014","journal-title":"Am J Med"},{"key":"2024062715575459200_ofae277-B16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cid\/cit419","article-title":"Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment","volume":"57","author":"Million","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/cit191","article-title":"Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis","volume":"57","author":"Million","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/520661","article-title":"Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy","volume":"45","author":"Carcopino","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/321889","article-title":"Risks factors and prevention of Q fever endocarditis","volume":"33","author":"Fenollar","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1086\/514698","article-title":"Q fever during pregnancy: a public health problem in southern France","volume":"27","author":"Stein","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/clinids\/14.1.127","article-title":"Acute and chronic Q fever in patients with cancer","volume":"14","author":"Raoult","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0163-4453(85)90870-9","article-title":"Coxiella burnetii infection in immunocompromised patients","volume":"11","author":"Heard","year":"1985","journal-title":"J Infect"},{"key":"2024062715575459200_ofae277-B23","doi-asserted-by":"crossref","first-page":"698121","DOI":"10.3389\/fimmu.2021.698121","article-title":"Sexual dimorphism and gender in infectious diseases","volume":"12","author":"Gay","year":"2021","journal-title":"Front Immunol"},{"key":"2024062715575459200_ofae277-B24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12879-019-4479-0","article-title":"Clinical characteristics of acute Q fever patients in South Korea and time from symptom onset to serologic diagnosis","volume":"19","author":"Heo","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2024062715575459200_ofae277-B25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s15010-010-0052-x","article-title":"One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings","volume":"38","author":"Limonard","year":"2010","journal-title":"Infection"},{"key":"2024062715575459200_ofae277-B26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/CMR.12.4.518","article-title":"Q fever","volume":"12","author":"Maurin","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"2024062715575459200_ofae277-B27","doi-asserted-by":"crossref","first-page":"ofac666","DOI":"10.1093\/ofid\/ofac666","article-title":"Karius with a Q: role for microbial cell-free DNA next-generation sequencing in diagnosis of acute Q fever","volume":"10","author":"Ranganath","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024062715575459200_ofae277-B28","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1128\/jcm.34.9.2270-2274.1996","article-title":"Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii","volume":"34","author":"La Scola","year":"1996","journal-title":"J Clin Microbiol"},{"key":"2024062715575459200_ofae277-B29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/JCM.37.3.558-564.1999","article-title":"Serologic testing for human granulocytic ehrlichiosis at a national referral center","volume":"37","author":"Comer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2024062715575459200_ofae277-B30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1086\/313701","article-title":"Q fever endocarditis associated with extensive serological cross-reactivity","volume":"30","author":"Graham","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B31","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1128\/JCM.41.11.5094-5098.2003","article-title":"Comparison of PCR and serology assays for early diagnosis of acute Q fever","volume":"41","author":"Fournier","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2024062715575459200_ofae277-B32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/516308","article-title":"Acute glomerulonephritis associated with acute Q fever: case report and review of the renal complications of Coxiella burnetii infection","volume":"26","author":"Korman","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B33","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/imj.14447","article-title":"Acute kidney injury in acute Q fever","volume":"49","author":"Stewart","year":"2019","journal-title":"Intern Med J"},{"key":"2024062715575459200_ofae277-B34","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/cid\/ciz120","article-title":"Acute Q fever endocarditis: a paradigm shift following the systematic use of transthoracic echocardiography during acute Q fever","volume":"69","author":"Melenotte","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B35","doi-asserted-by":"crossref","first-page":"100940","DOI":"10.1016\/j.nmni.2021.100940","article-title":"Pancreatitis, hypereosinophilia and bilateral pulmonary infiltrates as presentation of acute Q fever","volume":"43","author":"Cancela Costa","year":"2021","journal-title":"New Microbes New Infect"},{"key":"2024062715575459200_ofae277-B36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cid\/civ956","article-title":"Antiphospholipid antibody syndrome with valvular vegetations in acute Q fever","volume":"62","author":"Million","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B37","doi-asserted-by":"crossref","first-page":"e7578","DOI":"10.1097\/MD.0000000000007578","article-title":"Thrombosis and antiphospholipid antibody syndrome during acute Q fever: a cross-sectional study","volume":"96","author":"Million","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2024062715575459200_ofae277-B38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2015-04-639617","article-title":"B-cell non-Hodgkin lymphoma linked to Coxiella burnetii","volume":"127","author":"Melenotte","year":"2016","journal-title":"Blood"},{"key":"2024062715575459200_ofae277-B39","doi-asserted-by":"crossref","first-page":"e4287","DOI":"10.1097\/MD.0000000000004287","article-title":"18F-FDG PET\/CT as a central tool in the shift from chronic Q fever to Coxiella burnetii persistent focalized infection: a consecutive case series","volume":"95","author":"Eldin","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2024062715575459200_ofae277-B40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/imj.1962.11.3.184","article-title":"Tetracycline in the treatment of \u201cQ\u201d fever","volume":"11","author":"Powell","year":"1962","journal-title":"Australas Ann Med"},{"key":"2024062715575459200_ofae277-B41","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1128\/AAC.45.12.3644-3646.2001","article-title":"Newer macrolides as empiric treatment for acute Q fever infection","volume":"45","author":"Gikas","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062715575459200_ofae277-B42","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1017\/S0950268810002621","article-title":"Antibiotic therapy for acute Q fever in the Netherlands in 2007 and 2008 and its relation to hospitalization","volume":"139","author":"Dijkstra","year":"2011","journal-title":"Epidemiol Infect"},{"key":"2024062715575459200_ofae277-B43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cid\/cit718","article-title":"Antibiotic prophylaxis for high-risk patients with acute Q fever: no definitive answers yet","volume":"58","author":"Kampschreur","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024062715575459200_ofae277-B44","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.cmi.2023.05.027","article-title":"Which trial do we need? Doxycycline vs doxycycline-hydroxychloroquine and treatment duration protocol for Q fever endovascular infections","volume":"29","author":"Paul","year":"2023","journal-title":"Clin Microbiol Infect"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae277\/57505580\/ofae277.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae277\/58216169\/ofae277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae277\/58216169\/ofae277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T15:24:04Z","timestamp":1719501844000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae277\/7668374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae277","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,5,10]]},"article-number":"ofae277"}}